Single-use bioreactors market was a rapidly growing segment within the biotechnology and pharmaceutical industries. Single-use bioreactors, also known as disposable bioreactors, are a type of bioreactor that is designed for single-use applications, offering various advantages over traditional stainless-steel bioreactors.
Request for Sample PDF @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750
Single-Use Bioreactors Market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR of 19.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as the increasing adoption of single-use bioreactors among startups and SMEs, lower operational complexity of single-use bioreactors compared to conventional stainless-steel bioreactors, reduced energy and water consumption, growing size of the biologics and biosimilars market, and technological advancements in single-use bioreactors.
Key factors driving the growth of the single-use bioreactors market include:
Cost-effectiveness: Single-use bioreactors eliminate the need for extensive cleaning and validation processes, reducing operational costs and saving time in-between batches.
Flexibility and scalability: These bioreactors are available in various sizes and configurations, making them suitable for a wide range of applications and allowing for easy scale-up or scale-down based on production needs.
Reduced cross-contamination risk: Since single-use bioreactors are disposable, the risk of cross-contamination between batches is minimized, which is particularly crucial in the production of biologics and vaccines.
Faster setup and turnaround times: The simplicity of setup and reduced cleaning requirements lead to faster turnaround times between batches, enhancing production efficiency.
Increasing demand for biologics and personalized medicine: The rise in demand for biopharmaceuticals, such as monoclonal antibodies and cell therapies, has driven the adoption of single-use bioreactors in biopharmaceutical manufacturing.
Support from regulatory bodies: Regulatory authorities, like the FDA, have recognized the benefits of single-use bioreactors in certain applications, leading to increased acceptance and adoption within the industry.
Browse Complete Report @ https://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html
The Asia Pacific region is the fastest-growing region of the single-use bioreactors market.
The Asia Pacific market is expected to register the highest CAGR during the forecast period. Factors such as the growing biopharmaceutical industry, rising investments by pharmaceutical & biotechnology companies, and the growing number of CROs & CMOs in several Asia Pacific countries are supporting the growth of the market in the region.
Key Market Players:
Key players in the single-use bioreactors Market are Sartorius AG (Germany), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany).
Recent Developments:
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=49113750
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Aashish MehraEmail: Send EmailPhone: 18886006441Address:630 Dundee Road Suite 430City: NorthbrookState: IL 60062Country: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html